High-throughput screening for mTORC1/mTORC2 kinase inhibitors using a chemiluminescence-based ELISA assay

Shripad V Bhagwat1, Jennifer Kahler, Yan Yao

  • 1Department of Cancer Biology, OSI Pharmaceuticals Inc., Farmingdale, New York 11735, USA. Sbhagwat@osip.com

Related Concept Videos